SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001235802-18-000171
Filing Date
2018-12-06
Accepted
2018-12-06 19:00:13
Documents
2
Period of Report
2018-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 16778
2 POWER OF ATTORNEY poa-giuffre.txt EX-24 3589
  Complete submission text file 0001235802-18-000171.txt   21851
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address
Giuffre Randall Michael (Reporting) CIK: 0001759822 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36291 | Film No.: 181221948